文献速递脊柱关节炎

TNF抑制剂可减缓放射学阳性中轴型脊柱关节炎患者的脊柱影像学进展

Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort.
PubMed 文献 · Arthritis Rheumatol · 2021-05-25

该前瞻性队列研究纳入314例符合改良纽约标准的放射学阳性中轴型SpA患者,每2年行脊柱X线并采用mSASSS评分,评估TNFi对mSASSS的间接效应(通过ASDAS)与直接效应。结果显示,持续使用TNFi者ASDAS对mSASSS的效应低于从未使用者(β=0.16 vs 0.41),且TNFi直接使mSASSS平均降低0.85单位,提示TNFi可减缓脊柱影像学进展,部分独立于炎症控制。

要点

  • TNFi持续治疗者ASDAS对mSASSS的效应低于从未治疗者(β=0.16 vs 0.41)。
  • TNFi直接使mSASSS平均降低0.85单位(β=-0.85,95%CI -1.35至-0.35)。
  • TNFi减缓脊柱影像学进展可能部分独立于ASDAS所测的炎症控制。

核心结论

  • TNFi可减缓放射学阳性中轴型SpA患者的脊柱影像学进展,且该作用可能部分独立于ASDAS所测炎症控制。

研究设计与样本

  • 前瞻性队列研究(ALBERTA随访研究),纳入314例符合改良纽约标准的放射学阳性中轴型SpA患者,每2年行脊柱X线、最长10年,由2名中心读片者采用mSASSS评分。

主要发现

  • ASDAS对后续mSASSS的效应呈梯度趋势(交互P=0.10),从未使用TNFi者β=0.41(95%CI 0.13至0.68),持续使用TNFi者β=0.16(95%CI 0.00至0.31)。
  • 调整基线ASDAS后,TNFi治疗者随访末期mSASSS平均比未治疗者低0.85单位(β=-0.85,95%CI -1.35至-0.35)。

关键数值与推荐

  • 采用改良纽约标准定义放射学阳性中轴型SpA;mSASSS用于脊柱影像学评分;ASDAS用于炎症评估。

临床怎么用

  • 对放射学阳性中轴型SpA患者,TNFi治疗可能有助于减缓脊柱结构损伤进展。
  • TNFi的 structural 保护作用不应仅以ASDAS改善作为唯一评估依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether tumor necrosis factor inhibitors (TNFi) impact spinal radiographic progression in patients with axial spondyloarthritis (SpA) and whether this is coupled to their effect on inflammation. METHODS: Patients with axial SpA fulfilling the modified New York criteria were included in a prospective cohort (the ALBERTA Follow Up Research Cohort in Ankylosing Spondylitis Treatment). Spine radiographs, performed every 2 years for up to 10 years, were scored by 2 central readers, using the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). The indirect effect of TNFi on mSASSS was evaluated with generalized estimating equations by testing the interaction between TNFi and Ankylosing Spondylitis Disease Activity Score (ASDAS) at the start of each 2-year interval (t). If significant, the association between ASDAS at t and mSASSS at the end of the interval (t+1) was assessed in 1) patients treated with TNFi at all visits, 2) patients treated with TNFi at some visits, and 3) patients who were never treated with TNFi. In addition, the association between TNFi at t and mSASSS at t+1 (adjusting for ASDAS at t) was also tested (direct effect). RESULTS: In total, 314 patients were included. A gradient was seen for the effect of ASDAS at t on mSASSS at t+1 (interaction P = 0.10), with a higher progression in patients never treated with TNFi (β = 0.41 [95% confidence interval (95% CI) 0.13, 0.68]) compared to those continuously treated (β = 0.16 [95% CI 0.00, 0.31]) (indirect effect). However, TNFi also directly slowed progression, as treated patients had on average an mSASSS 0.85 units lower at t+1 compared to untreated patients (β = -0.85 [95% CI -1.35, -0.35]). CONCLUSION: Our findings indicate that TNFi reduce spinal radiographic progression in patients with radiographic axial SpA, which might be partially uncoupled from their effects on inflammation as measured by the ASDAS.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Sepriano A, Ramiro S, Wichuk S, et al. Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort. Arthritis Rheumatol. 2021. PMID: 33538097. doi:10.1002/art.41667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。